Primary and Secondary Care Collaboration in Clinical Research

Overview

Journal Future Healthc J

Specialty Health Services

Date 2024 Jan 1

PMID 38162215

Authors

Nicholas Pb Thomas

Emma Tonner

Simon Royal

Philip Evans

Affiliations

Soon will be listed here.

Abstract

More patients are seen in primary care than in any other part of the health system in the UK. Our NHS datasets are the envy of the world and provide us with huge opportunities to support our patients and populations. In this paper, we demonstrate the breadth of primary care research, recruitment and delivery options. We show how research can affect many different aspects of patient care and demonstrate, through the delivery and publication of game-changing research, the ability of recruitment in primary care to answer questions that are relevant to secondary care activity. Indeed, these complex and innovative study designs and their collaborative delivery across the multitude of diseases (acute and chronic) show the strength of primary care. Collaboration across boundaries, specialties and healthcare settings will provide increased opportunities for clinical research development and, most importantly, deliver the highest quality research to support our patients.

Citing Articles

Progress in primary and integrated care.

Hawthorne K, Rafi I Future Healthc J. 2024; 10(3):177.

PMID: 38162218 PMC: 10753213. DOI: 10.7861/fhj.ed.10.3.2.

References

Wang X, Mobley A, Tica O, Okoth K, Ghosh R, Myles P . Systematic approach to outcome assessment from coded electronic healthcare records in the DaRe2THINK NHS-embedded randomized trial. Eur Heart J Digit Health. 2023; 3(3):426-436. PMC: 9708037. DOI: 10.1093/ehjdh/ztac046. View

Horby P, Lim W, Emberson J, Mafham M, Bell J, Linsell L . Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2020; 384(8):693-704. PMC: 7383595. DOI: 10.1056/NEJMoa2021436. View

Faulkner-Gurstein R, Wyatt D, Cowan H, Hare N, Harris C, Wolfe C . The organization and impacts of clinical research delivery workforce redeployment during the COVID-19 pandemic: a qualitative case study of one research-intensive acute hospital trust. Health Res Policy Syst. 2022; 20(1):68. PMC: 9206093. DOI: 10.1186/s12961-022-00876-5. View

. Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial. Lancet. 2021; 397(10279):1063-1074. PMC: 7972318. DOI: 10.1016/S0140-6736(21)00461-X. View

Sheppard J, Burt J, Lown M, Temple E, Lowe R, Fraser R . Effect of Antihypertensive Medication Reduction vs Usual Care on Short-term Blood Pressure Control in Patients With Hypertension Aged 80 Years and Older: The OPTIMISE Randomized Clinical Trial. JAMA. 2020; 323(20):2039-2051. PMC: 7251449. DOI: 10.1001/jama.2020.4871. View

Butler C, Hobbs F, Gbinigie O, Rahman N, Hayward G, Richards D . Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial. Lancet. 2022; 401(10373):281-293. PMC: 9779781. DOI: 10.1016/S0140-6736(22)02597-1. View

Butler C, Yu L, Dorward J, Gbinigie O, Hayward G, Saville B . Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial. Lancet Respir Med. 2021; 9(9):1010-1020. PMC: 8315758. DOI: 10.1016/S2213-2600(21)00310-6. View

Edwards L, Pickett J, Ashcroft D, Dambha-Miller H, Majeed A, Mallen C . UK research data resources based on primary care electronic health records: review and summary for potential users. BJGP Open. 2023; 7(3). PMC: 10646196. DOI: 10.3399/BJGPO.2023.0057. View

Bower P, Grigoroglou C, Anselmi L, Kontopantelis E, Sutton M, Ashworth M . Is health research undertaken where the burden of disease is greatest? Observational study of geographical inequalities in recruitment to research in England 2013-2018. BMC Med. 2020; 18(1):133. PMC: 7232839. DOI: 10.1186/s12916-020-01555-4. View

10.

Hayward G, Butler C, Yu L, Saville B, Berry N, Dorward J . Platform Randomised trial of INterventions against COVID-19 In older peoPLE (PRINCIPLE): protocol for a randomised, controlled, open-label, adaptive platform, trial of community treatment of COVID-19 syndromic illness in people at higher risk. BMJ Open. 2021; 11(6):e046799. PMC: 8214989. DOI: 10.1136/bmjopen-2020-046799. View

11.

Butler C, Gillespie D, White P, Bates J, Lowe R, Thomas-Jones E . C-Reactive Protein Testing to Guide Antibiotic Prescribing for COPD Exacerbations. N Engl J Med. 2019; 381(2):111-120. DOI: 10.1056/NEJMoa1803185. View

12.

McManus R, Mant J, Franssen M, Nickless A, Schwartz C, Hodgkinson J . Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial. Lancet. 2018; 391(10124):949-959. PMC: 5854463. DOI: 10.1016/S0140-6736(18)30309-X. View

13.

Man M, Chaplin K, Mann C, Bower P, Brookes S, Fitzpatrick B . Improving the management of multimorbidity in general practice: protocol of a cluster randomised controlled trial (The 3D Study). BMJ Open. 2016; 6(4):e011261. PMC: 4854003. DOI: 10.1136/bmjopen-2016-011261. View

14.

Jonker L, Fisher S . The correlation between National Health Service trusts' clinical trial activity and both mortality rates and care quality commission ratings: a retrospective cross-sectional study. Public Health. 2018; 157:1-6. DOI: 10.1016/j.puhe.2017.12.022. View

15.

Yu L, Bafadhel M, Dorward J, Hayward G, Saville B, Gbinigie O . Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial. Lancet. 2021; 398(10303):843-855. PMC: 8354567. DOI: 10.1016/S0140-6736(21)01744-X. View

16.

Fong Y, McDermott A, Benkeser D, Roels S, Stieh D, Vandebosch A . Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial. Nat Microbiol. 2022; 7(12):1996-2010. PMC: 10166187. DOI: 10.1038/s41564-022-01262-1. View

17.

Fitzgerald R, di Pietro M, ODonovan M, Maroni R, Muldrew B, Debiram-Beecham I . Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial. Lancet. 2020; 396(10247):333-344. PMC: 7408501. DOI: 10.1016/S0140-6736(20)31099-0. View

18.

de Lusignan S, Correa A, Smith G, Yonova I, Pebody R, Ferreira F . RCGP Research and Surveillance Centre: 50 years' surveillance of influenza, infections, and respiratory conditions. Br J Gen Pract. 2017; 67(663):440-441. PMC: 5604796. DOI: 10.3399/bjgp17X692645. View